Suppr超能文献

他唑巴坦/哌拉西林或他唑巴坦的生殖和发育毒性研究(3)——大鼠腹腔注射给药的围产期和产后研究

[Reproductive and developmental toxicity studies of tazobactam/piperacillin or tazobactam (3)--Perinatal and postnatal study in rats with intraperitoneal administration].

作者信息

Sato T, Hoberman A M, Christian M S

机构信息

Drug Safety Laboratory, Taiho Pharmaceutical Co., Ltd., Tokushima, Japan.

出版信息

J Toxicol Sci. 1994 Oct;19 Suppl 2:233-47. doi: 10.2131/jts.19.supplementii_233.

Abstract

Tazobactam (TAZ) is a newly developed beta-lactamase inhibitor and piperacillin (PIPC) is an antibiotics which is used in clinical field widely. The combination of TAZ and PIPC (TAZ/PIPC), which is combined with TAZ and PIPC at rate of 1:4, has been developed because of PIPC is unstable to various beta-lactamases. Perinatal and postnatal toxicity were studied in rats given daily intraperitoneal doses of TAZ/PIPC (200, 800 or 1600 mg/kg/day) or TAZ (40, 320 or 1280 mg/kg/day). TAZ/PIPC or TAZ were given from day 17 of pregnancy through day 21 of lactation. Total daily doses were administered in two equally divided doses. In this study, evaluation of the late stage of gestation, parturition, lactation and maternal behavior in adult rats and postnatal evaluation of the growth and development, and reproductive performance of the F1 generation occurred. In the TAZ/PIPC, maternal toxicity (decreased food consumption) was observed at 800 and 1600 mg/kg groups during perinatal period. A slight decrease in body weight gain during perinatal period and increased pup mortality and decreased pup weight in lactation period were observed at 1600 mg/kg group. An increase in stillbirths also was observed at 1600 mg/kg group. In the TAZ, maternal toxicity (decreased food consumption) was observed at all dosage groups during perinatal period. A decrease in body weight gain also were observed during perinatal period at 1280 mg/kg group. At maternotoxic doses of 320 and 1280 mg/kg groups, decreased pup weight were observed during lactation period. An increase in stillbirths also was observed at 1280 mg/kg group. Transient, significant decrease in pup body weights at 1280 mg/kg group in early postweaning period. No other effects occurred for the F1 generation rats. In conclusion, perinatal development and postnatal growth and development of offspring were affected only at the intermediate and high doses that caused maternal toxicity in this study. Therefore it is seemed that non-observed effect dose levels (NOELs) of TAZ/PIPC for dams is less than 200 mg/kg/day and that of TAZ is less than 40 mg/mg/day, and NOELs of TAZ/PIPC is 200 mg/kg/day and that of TAZ is 40 mg/kg/day for offspring under the condition of this study.

摘要

他唑巴坦(TAZ)是一种新开发的β-内酰胺酶抑制剂,哌拉西林(PIPC)是一种临床上广泛使用的抗生素。由于PIPC对各种β-内酰胺酶不稳定,因此开发了他唑巴坦与哌拉西林的组合制剂(TAZ/PIPC),其TAZ与PIPC的配比为1:4。对每日腹腔注射TAZ/PIPC(200、800或1600mg/kg/天)或TAZ(40、320或1280mg/kg/天)的大鼠进行围产期和产后毒性研究。从妊娠第17天至哺乳期第21天给予TAZ/PIPC或TAZ。每日总剂量分两次等量给药。在本研究中,对成年大鼠的妊娠后期、分娩、哺乳和母性行为进行了评估,并对F1代的生长发育和生殖性能进行了产后评估。在TAZ/PIPC组中,围产期800和1600mg/kg组观察到母体毒性(食物摄入量减少)。1600mg/kg组在围产期体重增加略有下降,哺乳期幼崽死亡率增加,幼崽体重下降。1600mg/kg组还观察到死产增加。在TAZ组中,围产期所有剂量组均观察到母体毒性(食物摄入量减少)。1280mg/kg组在围产期体重增加也有所下降。在320和1280mg/kg的母体毒性剂量组中,哺乳期幼崽体重下降。1280mg/kg组也观察到死产增加。1280mg/kg组在断奶后早期幼崽体重出现短暂、显著下降。F1代大鼠未出现其他影响。总之,在本研究中,仅在引起母体毒性的中、高剂量下,后代的围产期发育以及产后生长发育受到影响。因此,在本研究条件下,TAZ/PIPC对母鼠的未观察到影响剂量水平(NOELs)小于200mg/kg/天,TAZ的未观察到影响剂量水平小于40mg/kg/天;TAZ/PIPC对后代的NOELs为200mg/kg/天,TAZ为40mg/kg/天。

相似文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验